Cytomegalovirus infection is a sexually transmitted disease caused by cytomegalovirus (cmv). Cytomegalovirus is a DNA virus. The characteristic lesions are enlarged infected cells with eosinophilic and basophilic inclusions in the nucleus and cytoplasm, respectively.CMV infection is distributed worldwide and humans are the only host of CMV. The rate of infection varies by country and economic status. There is a close relationship between CMV infection and immune function in adults. How can we effectively prevent increased cellular infections? Cytomegalovirus infection can be treated by applying various antiviral agents such as GCV, anti-cytomegalovirus immunoglobulin agents, interferon and transfer factor. However, these drugs do not solve the fundamental problem, and often the virus rises again latently after stopping the drugs. In view of the fact that such virus may serve as one of the causes of AIDS, scholars from various countries are devoted to the research of controlling its infection. Recently, American scholars have developed two live vaccines, which have been effective after initial trials. One was developed from the AD169 strain; the other was made from the TOWN strain, and has shown significant anti-cytomegalovirus efficacy after non-intestinal administration, with elevated CMV antibodies and enhanced immune function. Cytomegalovirus infection disease Western medical treatment 1, can apply a variety of antiviral system squeezed such as GCV, anti-cytomegalovirus immunoglobulin preparations, interferon and transfer factor. However, these drugs do not solve the fundamental problem, and often the virus rises again latently after stopping the drug. 2, recently, the United States scholars developed two live vaccines after the first trial is quite effective. One is developed from AD169 strain; the other is made from TOWN strain, after the non-intestinal administration, has clearly demonstrated the effectiveness of anti-cytomegalovirus, CMV antibodies rise, resulting in enhanced immune function. 3, propoxyphene (ganciclovirDHPG) has a role in preventing the spread of CMV If combined with high titers of anti-CMV immunoglobulin, it can reduce the mortality rate of CMV pneumonia complications of bone marrow transplantation, if propoxyphene-resistant CMV infection can be used sodium phosphate, although it can reduce the spread of CMV in a lasting way, but the effect is worse than the former. 4, acyclovir (acyclic guanosine) and adenosine treatment of other herpes virus disease effective, but not for CMV infection, but acyclovir derivative DHPG (9-guanosine) in the test tube stronger than acyclovir 25-50 times, but its side effects are also large, neutropenia is its most important side effects, efficacy and safety to be further studied.